DGX

NYSEStock

Quest Diagnostics Incorporated

$201.49+0.90 (+0.45%)

52-Week Range

$159.80

$211.91

Key Stats

Market Cap

22.4B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Volume

382.7K

Avg Volume

775.1K

Performance

-4.03%

+9.11%

+11.22%

YTD

+15.59%

+18.99%

+50.02%

+62.84%

Price Chart

ETF Exposure

DGX is held by 309 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
INRO	iShares U.S. Industry Rotation Active ETF	0.00%	4	$803	$32.6M	0.42%
BBAG	JPMorgan BetaBuilders U.S. Aggregate Bond ETF	0.00%	7,000	$7K	$1.14B	0.03%
LVHB	Innovator Laddered Allocation Power Buffer ETF	0.00%	833	$114K	$782.6M	0.10%
AVSU	Avantis Responsible U.S. Equity ETF	0.00%	10	$2K	$412.5M	0.15%
CHEP	AGFiQ U.S. Market Neutral Value Fund	0.00%	29	$0	$747K	1.42%
FTLS	First Trust Long/Short Equity ETF	0.00%	10,861	$0	$2.16B	1.38%
GTO	Invesco Total Return Bond ETF	0.00%	1,000	$1K	$2.10B	0.35%
JCPB	JPMorgan Core Plus Bond ETF	0.00%	55,000	$52K	$10.58B	0.38%

PreviousPage 7 of 7

About DGX ETF Exposure

Quest Diagnostics Incorporated (DGX) is held by 309 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 22.4B, DGX is a widely held institutional stock. The stock currently trades at $201.49. Investors can gain exposure to DGX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DGX, sorted by portfolio weight.